SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen – Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin
Jürgen Behr(Ludwig-Maximilians-Universität München), Michael Kreuter(Johannes Gutenberg University Mainz), Elvira Stacher‐Priehse(Asklepios Fachkliniken München-Gauting), Antje Prasse(University Medical Center Freiburg), Lars Hagmeyer(Krankenhaus Bethanien), Hortense Slevogt(Jena University Hospital), Sven Gläser(Vivantes Klinikum), Francesco Bonella(Ruhrlandklinik), Nikolaus Kneidinger(German Center for Lung Research), Dirk Koschel, Julien Dinkel(LMU Klinikum), Torsten Blum(MSB Medical School Berlin), Melanie Berger(Witten/Herdecke University), Holger Woehrle(ResMed (United States))
Cited by 2
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Sarcoidosis
|The Lancet|2013|1.1k
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k